Showing 59,981 - 60,000 results of 74,138 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((mean decrease) OR (we decrease)) ))', query time: 1.42s Refine Results
  1. 59981

    Single-Cell Electroporation Can Be Carried Out at High Efficiency by Front-Loading Micropipettes. by Joseph D. Steinmeyer (170118)

    Published 2012
    “…<p>(a) In a micropipette filled with saline (scale bar 1 mm), a front-loaded reagent diffuses over time, decreasing concentration of the sample at the tip (drawings are not to scale). …”
  2. 59982

    Identification of Vascular and Hematopoietic Genes Downstream of <em>etsrp</em> by Deep Sequencing in Zebrafish by Gustavo Gomez (114453)

    Published 2012
    “…<div><p>The transcription factor <em>etsrp</em>/<em>Er71</em>/<em>Etv2</em> is a master control gene for vasculogenesis in all species studied to date. …”
  3. 59983

    48-week chase analysis of BrdU-labeled cells and Ki67-positive cells. by Shinji Kobayashi (200371)

    Published 2011
    “…<p>BrdU-labeled cells gradually decreased in auricular cartilage (White arrowheads). …”
  4. 59984

    Effect of the labeling on cell viability, proliferation, and differentiation capacity. by Philipp Boehm-Sturm (190121)

    Published 2011
    “…<p>Photomicrographs of <i>in vitro</i> samples stained for Ki67 (A, B, I and J), nestin (C, F E and H), GFAP (D, E G, H, K and N), and βIII-tubulin (L, M, O and P). …”
  5. 59985

    The <i>Scact1</i> strain is sensitive to the F-actin stabilizing agent, jasplakinolide. by Lawrence L. LeClaire (90449)

    Published 2015
    “…Effects on WT and <i>Scact1</i> growth at 50 μg/ml jasplakinolide are shown. Jasplakinolide treatment was associated with decreased growth, increased branching and swollen hyphal tips (white arrowhead, enlarged panel to right).…”
  6. 59986

    <i>In silico</i> modeling of proCART. by Elías H. Blanco (391481)

    Published 2013
    “…Alanine substitution decreases the amphipathicity. (D) Alignment of proCART from several species. proCART alpha-helix structures predicted by <a href="mailto:NPS@" target="_blank">NPS@</a> server (amino acids 24–37 for human, and 36–50 for rodent isoform are underlined. …”
  7. 59987
  8. 59988

    Reinforced Two-Choice Assay and Go/No Go Assay using PROBES. by Qiang Qiu (412276)

    Published 2014
    “…Chance level of discrimination is 50%, indicated by a dashed line. <b>C</b>) Training curve in a Go/No Go training using AA as reward odor (CS+, 1∶100, v/v) and MO (CS−). …”
  9. 59989

    Network firing activity during spontaneous and stimulated conditions. by Gustavo Deco (50143)

    Published 2013
    “…<p>The network cohesion and inhibition levels are and , respectively. (<b>A</b>) Firing activity for network neurons (10 neurons in each population, as indicated on the right): raster plot (black) together with the mean rate (red curves) for each population, obtained as the convolution of the spike trains with a unit Gaussian function with 50 ms width. …”
  10. 59990
  11. 59991

    Video2_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.MP4 by Kai Wang (21246)

    Published 2023
    “…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD<sub>90</sub> prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”
  12. 59992

    Video2_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.MP4 by Kai Wang (21246)

    Published 2023
    “…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD<sub>90</sub> prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”
  13. 59993

    DataSheet_1_Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus Infections.pdf by Fernando Echegaray (11176926)

    Published 2021
    “…Sensitivity increased (53% non-endemic, 98% endemic) when tests were allowed to run beyond manufacturer recommendations (0.5 up to 3 hours), but specificity decreased in endemic samples (36%). …”
  14. 59994

    Presentation1_Comprehensive evaluation of time-varied outcomes for invasive and conservative strategies in patients with NSTE-ACS: a meta-analysis of randomized controlled trials.p... by Yi-Jing Zhao (16954137)

    Published 2023
    “…Trial data for studies with a minimum follow-up time of 30 days were included. We categorized the follow-up time into six varied periods, namely, ≤6 months, 1 year, 2 years, 3 years, 5 years, and ≥10 years. …”
  15. 59995

    Data_Sheet_1_Epidemiological characteristics and transmission dynamics of the COVID-19 outbreak in Hohhot, China: a time-varying SQEIAHR model analysis.xlsx by Yifei Ma (206062)

    Published 2023
    “…</p>Methods<p>In this study, we first investigated the epidemiological characteristics of COVID-19 cases in Hohhot, including the spatiotemporal distribution and sociodemographic distribution. …”
  16. 59996

    Image2_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.TIF by Kai Wang (21246)

    Published 2023
    “…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD<sub>90</sub> prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”
  17. 59997

    Planning ahead: Dynamic models forecast blue whale distribution with applications for spatial management (data and code) by Dawn Barlow (8294067)

    Published 2021
    “…</div><div>5.Synthesis and applications: We develop and test ecological forecast models that predict sea surface temperature, net primary productivity, and blue whale suitable habitat up to three weeks in the future within New Zealand’s South Taranaki Bight region. …”
  18. 59998

    Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting by Zsolt Fejes (844136)

    Published 2018
    “…We studied the effect of everolimus on E-selectin (SELE) and VCAM1 mRNA levels when human coronary artery (HCAECs) and human umbilical vein ECs were challenged with recombinant TNF-α (100 ng/mL) for 1–24 hours in the presence or absence of everolimus using 0.5 μM concentration locally maintained by DES. …”
  19. 59999

    Video1_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.MP4 by Kai Wang (21246)

    Published 2023
    “…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD<sub>90</sub> prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”
  20. 60000

    Image4_Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.TIF by Kai Wang (21246)

    Published 2023
    “…We found that chronic mavacamten treatment of R403Q ECTs: (i) shortened relaxation time, (ii) reduced APD<sub>90</sub> prolongation, (iii) upregulated ADRB2, ATP2A2, RYR2, and CACNA1C, (iv) decreased B-type natriuretic peptide (BNP) mRNA and protein expression levels, and (v) increased sarcomere length and reduced sarcomere disarray.…”